Home>Publications>Impact of HSD11B1 polymorphisms on body mass index and components of the metabolic syndrome in patients with psychotropic treatments
Quteineh L, Vandenberghe F, Saigi-Morgui N, Delacretaz A, Choong E, Gholamrezaee M, von Gunten A, Preisig M, Castelao E, Vollenweider P, Kutalik Z, Conus P, Eap C. Impact of HSD11B1 polymorphisms on body mass index and components of the metabolic syndrome in patients with psychotropic treatments. Presented at the 2015 World Congress of Biological Psychiatry; June 2015. Athens, Greece.
Abstract not available at this time.
RTI Health Solutions®
The power of knowledge. The value of understanding.
Steeped in a tradition of rigor and process, we maintain a legacy of setting the scientific standards within our industry. We employ the right approaches and proven research practices to analyze evidence and draw meaningful insights. Our uncompromisingly ethical and objective researchers ensure that results will hold up to scrutiny and reveal the benefits, risks, value and potential of your products. Learn more.